RAPT Therapeutics (RAPT) Other Gross PP&E Adjustments (2020 - 2024)
Historic Other Gross PP&E Adjustments for Therapeutics (RAPT) over the last 5 years, with Q3 2024 value amounting to $7.4 million.
- Therapeutics' Other Gross PP&E Adjustments rose 3276.45% to $7.4 million in Q3 2024 from the same period last year, while for Sep 2024 it was $7.4 million, marking a year-over-year increase of 3276.45%. This contributed to the annual value of $349000.0 for FY2023, which is 161739.13% up from last year.
- As of Q3 2024, Therapeutics' Other Gross PP&E Adjustments stood at $7.4 million, which was up 3276.45% from $6.9 million recorded in Q2 2024.
- Over the past 5 years, Therapeutics' Other Gross PP&E Adjustments peaked at $10.0 million during Q1 2021, and registered a low of -$23000.0 during Q4 2022.
- Its 5-year average for Other Gross PP&E Adjustments is $6.5 million, with a median of $6.9 million in 2024.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first tumbled by 10028.42% in 2022, then surged by 161739.13% in 2023.
- Over the past 5 years, Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at $8.8 million in 2020, then dropped by 7.93% to $8.1 million in 2021, then plummeted by 100.28% to -$23000.0 in 2022, then soared by 1617.39% to $349000.0 in 2023, then surged by 2017.77% to $7.4 million in 2024.
- Its last three reported values are $7.4 million in Q3 2024, $6.9 million for Q2 2024, and $6.6 million during Q1 2024.